Trimethylamine-N-oxide promotes vascular aging via inhibiting GATA4 degradation in chronic kidney disease rats
{{output}}
A high percentage of chronic kidney disease (CKD) patients suffer from vascular aging. It has been demonstrated that trimethylamine N-oxide (TMAO) is an important indicator of cardiovascular events in patients with CKD. However, there is no clear understanding... ...
